Here is what each key variant contributes to the picture of why your GLP-1 may or may not be working as expected: TCF7L2 (rs7903146, rs12255372) Incretin pathway efficiency: TCF7L2 is the strongest common genetic predictor of type 2 diabetes risk, and the mechanism runs directly through incretin hormone function
Furthermore, GE2 treatment led to weight loss, enhanced cued and contextual fear memory, reduced inflammation in the hippocampus in SD rats and increased neurogenesis in the dorsal hippocampus
The GI side effect timeline provides benchmarks for normal duration versus concerning persistence
This has made the drug buzzy not just among people looking to lose a few (or few dozen) pounds, but with athletes, weightlifters, and body composition obsessives
Others decide that the weight loss and metabolic health benefits of medications like tirzepatide outweigh the temporary inability to donate plasma
Clayman, MD, FACS, FACE, senior author of the white paper and an extremely high-volume thyroid cancer surgeon